Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

12.32 -0.06 (-0.48%)
Streaming Delayed Price Updated: 1:45 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 858,761
Open 12.40
Bid (Size) 12.32 (100)
Ask (Size) 12.33 (500)
Prev. Close 12.38
Today's Range 12.30 - 12.60
52wk Range 4.720 - 15.32
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Cash-Burning Stocks with Warning Signs
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
Via StockStory
Topics Electric Vehicles

Performance

YTD
+4.8%
+4.8%
1 Month
+0.2%
+0.2%
3 Month
+19.8%
+19.8%
6 Month
+141.6%
+141.6%
1 Year
-18.8%
-18.8%

More News

Read More
News headline image
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Russell 2000 Stocks We Think Twice About
Via StockStory
News headline image
3 Stocks Under $50 We Steer Clear Of
Via StockStory
News headline image
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present New ctDNA Research at SABCS 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
Via StockStory
News headline image
3 Overrated Stocks That Concern Us
Via StockStory
News headline image
1 Cash-Burning Stock to Research Further and 2 We Brush Off
Via StockStory
Topics Retirement
News headline image
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
1 High-Flying Stock on Our Buy List and 2 We Find Risky
Via StockStory
News headline image
Earnings Scheduled For November 14, 2025 ↗
Via Benzinga
News headline image
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
Via StockStory
News headline image
3 Volatile Stocks We Keep Off Our Radar
Via StockStory
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
From NeoGenomics, Inc.
Via Business Wire
News headline image
The Top 5 Analyst Questions From NeoGenomics’s Q3 Earnings Call
Via StockStory
Topics Earnings
News headline image
NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
Topics Stocks
News headline image
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
From NeoGenomics, Inc.
Via Business Wire
News headline image
NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook
Via StockStory
News headline image
NeoGenomics (NEO) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Why NeoGenomics (NEO) Stock Is Trading Up Today
Via StockStory
Topics World Trade

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 12.32
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 01/29/26 01:45 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.51B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.